Screener
Upstream Bio, Inc. UPB Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-343417
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Accounts payable | (412) | (1,456) |
| Accrued expenses and other current liabilities | (3,060) | 1,674 |
| Operating lease liabilities | (315) | (273) |
| Net cash used in operating activities | (83,473) | (80,404) |
| Cash flows from investing activities: | ||
| Purchases of short-term investments | (65,363) | (323,138) |
| Maturities of short-term investments | 123,524 | 122,577 |
| Purchases of equipment | — | (47) |
Item 1. Financial Statements.
FAQ
- What is Upstream Bio, Inc.'s operating cash flow?
- Upstream Bio, Inc. (UPB) reported operating cash flow of -$35.62M in Q2 2026.
- How has Upstream Bio, Inc.'s operating cash flow changed year-over-year?
- Upstream Bio, Inc.'s operating cash flow increased by 9.2% year-over-year, from -$39.24M to -$35.62M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Upstream Bio, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude